GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Balchem Corp (NAS:BCPC) » Definitions » Revenue

BCPC (Balchem) Revenue : $964.5 Mil (TTM As of Mar. 2025)


View and export this data going back to 1986. Start your Free Trial

What is Balchem Revenue?

Balchem's revenue for the three months ended in Mar. 2025 was $250.5 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2025 was $964.5 Mil. Balchem's Revenue per Share for the three months ended in Mar. 2025 was $7.64. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was $29.44.

Warning Sign:

Balchem Corp revenue growth has slowed down over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Balchem was 2.90% per year. During the past 3 years, the average Revenue per Share Growth Rate was 6.00% per year. During the past 5 years, the average Revenue per Share Growth Rate was 8.70% per year. During the past 10 years, the average Revenue per Share Growth Rate was 6.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Balchem's highest 3-Year average Revenue per Share Growth Rate was 38.20% per year. The lowest was 2.00% per year. And the median was 11.70% per year.


Balchem Revenue Historical Data

The historical data trend for Balchem's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Balchem Revenue Chart

Balchem Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 703.64 799.02 942.36 922.44 953.68

Balchem Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 239.66 234.08 239.94 240.00 250.52

Competitive Comparison of Balchem's Revenue

For the Specialty Chemicals subindustry, Balchem's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Balchem's Revenue Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Balchem's Revenue distribution charts can be found below:

* The bar in red indicates where Balchem's Revenue falls into.


;
;

Balchem Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $964.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Balchem  (NAS:BCPC) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Balchem Revenue Related Terms

Thank you for viewing the detailed overview of Balchem's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Balchem Business Description

Traded in Other Exchanges
Address
5 Paragon Drive, Montvale, NJ, USA, 07645
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.
Executives
Van Gunsteren Job Leonard officer: Vice President 52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
William A. Backus officer: Chief Accounting Officer 52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
Michael Robert Sestrick officer: Chief Technology Officer 52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
David B Fischer director 425 WINTER ROAD, DELAWARE OH 43015
Michael Bent Tignor officer: Chief Human Resources Officer 52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
Matthew David Wineinger director 3605 GRAND VIEW COURT, ST CHARLES IL 60175
Theodore L Harris director, officer: President and CEO 5200 BLAZER PARKWAY, DUBLIN OH 43017
Olivier Rigaud director CORBION NV, PIET HEINKADE 127, AMSTERDAM P7 1019 GM
Monica Vicente director C/O FRESH DEL MONTE PRODUCE INC., P.O. BOX 149222, CORAL GABLES FL 33114
Frederic Boned officer: SVP/GM, Human Nutri. & Health 5 PARAGON DRIVE, MONTVALE NJ 07645
Hatsuki Miyata officer: General Counsel and Secretary 5 PARAGON DRIVE, MONTVALE NJ 07645
Jonathan Harrison Griffin officer: Vice President 52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
Martin Luther Reid officer: Chief Supply Chain Officer 52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
Kathleen B Fish director ONE PROCTER & GAMBLE PLAZA, CINCINNATI OH 45202
James C Hyde officer: Sr. Vice President 52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958